Elsayed S. Moubarak: Evaluating Established and Emerging Biomarkers in Hemophilia A and B Management
Elsayed S. Moubarak, Member of NEGIDA Corporation, Researcher at Research Medical Center, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”I’m pleased to share that our recent review article has been published in ASIDE Internal Medicine.
In this narrative review, we explored established and emerging biomarkers in Hemophilia A and B, highlighting their diagnostic, prognostic, and therapeutic implications in the era of extended half-life therapies, non-factor treatments, and gene therapy.
The review discusses:
- FVIII/FIX activity assays and inhibitor testing
- Genotyping approaches
- Global hemostasis assays
- Pharmacokinetic-guided prophylaxis
- Novel inflammatory and angiogenic markers linked to arthropathy
I am honored to contribute as Second Author and Corresponding Author on this work.
Grateful to my co-authors for their collaboration and dedication.”
Title: Biomarkers in Hemophilia: Diagnostic, Prognostic, and Treatment-Selection Utility: A Narrative Review of the Literature
Authors: Dalia Atef Abouda, Elsayed S. Moubarak, Fatma ElBadrawy, Malak A. Hassan, Mohamed Mohsen Helal, Abdallah M. Ibrahim, Hassan H. Eladl, Mohammad Mahadin, Mohamed Elsaid
Read the Full Article on ASIDE Internal Medicine Journal
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering